RxSight, Inc. Reports Preliminary Financial Results for the Second Quarter of 2026

Published on July 8, 2026
ALISO VIEJO, Calif.—RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company focused on improving vision after cataract surgery, has announced select preliminary financial results for the second quarter of 2026 and provided updates to its standalone product pipeline. This follows the announcement on July 6 about the company’s strategic collaboration with Alcon to develop and commercialize light-adjustable presbyopia-correcting intraocular lenses. Total company revenue for the second quarter of 2026 is expected to be approximately $32 million to $34 million, which includes $5 million to $7 million in revenue recognized from the RxSight Alcon strategic collaboration, with the specific amount expected to be reported in August with the company’s financial results for the second quarter of 2026.
Continue reading on website
Other news

RestoringVision Partners With Government of Saint Lucia to Broaden Access to Vision Care

July 8, 2026
SAINT LUCIA—RestoringVision announced it has signed a memorandum of understanding (MoU) with the government of Saint Lucia to expand access to essential vision care services, marking a significant step toward improving eye health and quality of life across the island. The agreement, signed on June 18, 2026, supports a Prime Ministerial Vision Initiative that will integrate presbyopia screening and

VSP Ventures Expands California Footprint With Six New Optometric Practices

July 8, 2026
RANCHO CORDOVA, Calif.—VSP Ventures, a VSP Vision company that provides practice transition options for private practice doctors of optometry, today announced that six new optometric practices across California have joined the organization. Now including more than 100 practices across the country, the six newest practices within VSP Ventures include Buena Vista Eyecare Optometry in San Jose, San G